U.S. markets close in 25 minutes
  • S&P 500

    3,668.09
    -25.14 (-0.68%)
     
  • Dow 30

    29,329.77
    -260.64 (-0.88%)
     
  • Nasdaq

    10,852.45
    -15.47 (-0.14%)
     
  • Russell 2000

    1,666.31
    -13.28 (-0.79%)
     
  • Crude Oil

    76.91
    -1.83 (-2.32%)
     
  • Gold

    1,634.60
    -21.00 (-1.27%)
     
  • Silver

    18.42
    -0.49 (-2.62%)
     
  • EUR/USD

    0.9620
    -0.0068 (-0.70%)
     
  • 10-Yr Bond

    3.8780
    +0.1810 (+4.90%)
     
  • GBP/USD

    1.0697
    -0.0159 (-1.47%)
     
  • USD/JPY

    144.6100
    +1.2900 (+0.90%)
     
  • BTC-USD

    19,181.17
    +206.89 (+1.09%)
     
  • CMC Crypto 200

    440.60
    +7.50 (+1.73%)
     
  • FTSE 100

    7,020.95
    +2.35 (+0.03%)
     
  • Nikkei 225

    26,431.55
    -722.28 (-2.66%)
     

Consumer Spending, E-Commerce, and the Business of Lodging

·20 min read

In this week's episode of Motley Fool Money, Motley Fool analyst Olivia Zitkus and Motley Fool contributor Keith Speights, along with host Chris Hill, discuss a new wave of biosimilar drugs and the challenges (and opportunities for investors) that they present. Shopify's (NYSE: SHOP) strong growth in 2021 being followed by an expectation for slightly less growth in 2022.